2Gladman DD, Shuckett R, Russell ML, et al. Psoriatic arthritis - an analysis of 220 patients [ J ]. Q J Med, 1987,62 (238) :127.
3Manna SK, Mukhopadhyay A, Aggarwal BB, et al Leflunomide suppresses TNF- induced cellular responses effects on NK- kappa B, activator protein- 1, c - jun N - terminal protein kinase and apoptosis [ J ]. J Immunol , 2000 165(10) :5 962.
4Reich K, Hummel KM, Beckmann I, et al. Treatment of severe psoriasis and psoriatic arthritis with leflunomide[ J] . Br J Dermatol,2002,146(2) :335.
5Cuchacovich M, Soto L. Letlunomide decreases joint earesion and induces reparative changes in a patient with psoriatic arthritis[J] .Ann Rheam Dia , 2002 , 61(10) :942.
6Ogilvie AL,Antoni C,Dechant C,Manger B,et al.Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate.Br J Dermtaol,2001,144:587-589.
7Kraan MC,van Kuijk AW,Dinant HJ,et al.Alefacept treatment in psoriatic arthritis:reduction of the effector T cell population in peripheral blood and synovial tissue is associated with improvement of clinical signs of arthritis.Arthritis Rheum,2002,46:2776
8Lacaille D,Stein HB,Raboud J,et al.Longterm therapy of psoriatic arthritis:intramuscular gold or methotrexate? J Rheumatol,2000,27:1922-1927.
9Sarzi-Puttini P,Santandrea S,Boccassini L,et al.The role of NSAIDs in psoriatic arthritis:evidence from a controlled study with nimesulide.Clin Exp Rheumatol,2001,19(Suppl 1):17-20.
10Reich K,Hummel KM,Beckmann I,et al.Treatment of severe psoriasis and psoriatic arthritis with leflunomide.Br J Dermatol,2002,146:335-336.
